Stay updated on Resmetirom in NASH and Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Resmetirom in NASH and Fibrosis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the Phase 3 MAESTRO-NASH resmetirom trial, including its design, eligibility criteria, outcomes, study locations, and publications, instead of a 403 error page.
    Difference
    100%
    Check dated 2026-11-07T15:36:20.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T16:12:30.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition notice and links to updates and FAQs, stating that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T19:24:21.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T22:00:29.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:00:24.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content and blocking access to the MAESTRO-NASH (NCT03900429) study details.
    Difference
    17%
    Check dated 2026-09-19T20:42:59.000Z thumbnail image

Stay in the know with updates to Resmetirom in NASH and Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.